禹洲集團(01628.HK):購回100萬美元優先票據
格隆匯7月12日丨禹洲集團(01628.HK)公佈,有關公司發行於2026年到期本金總額為6.45億美元的7.375%有擔保優先票據("2026年票據I")。於2021年7月12日,公司於公開市場購買本金總額為100萬美元的2026年票據I,連同此前若干時間內於公開市場購買的本金總額為150萬美元的2026年票據I,合計佔2026年票據I初始發行本金總額約0.39%。
已購回的2026年票據I將根據其條款及契約予以註銷。
於註銷已購回2026年票據I後,2026年票據I的未償還本金額將為6.375億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.